A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging.
about
A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transferLaunching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculaturePositron emission tomography (PET) imaging with (18)F-based radiotracersCombinatorial peptide libraries: mining for cell-binding peptides.Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse.Combinatorial ligand-directed lung targeting.Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Phage display in molecular imaging and diagnosis of cancer.Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.Phage display and molecular imaging: expanding fields of vision in living subjects.Oncolytic adenoviruses armed with thymidine kinase can be traced by PET imaging and show potent antitumoural effects by ganciclovir dosing.Hybrid Nanomaterial Complexes for Advanced Phage-guided Gene DeliveryLigand-directed profiling: applications to target drug discovery in cancer.Arterial embolization hyperthermia using As2O3 nanoparticles in VX2 carcinoma-induced liver tumors.Bacteriophage Mediates Efficient Gene Transfer in Combination with Conventional Transfection Reagents.Proteasome inhibition in cancer is associated with enhanced tumor targeting by the adeno-associated virus/phage.AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas.Design of virus-based nanomaterials for medicine, biotechnology, and energy.Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes.The natural dietary genistein boosts bacteriophage-mediated cancer cell killing by improving phage-targeted tumor cell transduction.Animal tumor models for PET in drug development.Chimeric adeno-associated virus and bacteriophage: a potential targeted gene therapy vector for malignant glioma.Phage Therapy in the Era of Synthetic Biology.Inhibition of histone deacetylation and DNA methylation improves gene expression mediated by the adeno-associated virus/phage in cancer cells.An AAVP-based solid-phase transducing matrix for transgene delivery: potential for translational applications.An investigation on stereospecific fluorination at the 2'-arabino-position of a pyrimidine nucleoside: radiosynthesis of 2'-deoxy-2'-[(18)F]fluoro-5-methyl-1-β-D-arabinofuranosyluracil.Dual systemic tumor targeting with ligand-directed phage and Grp78 promoter induces tumor regression.Targeting mammalian organelles with internalizing phage (iPhage) libraries.Evolution of phage display: from bioactive peptides to bioselective nanomaterials
P2860
Q24616181-4B568FE0-77AF-4765-AFCB-53CB7F306A61Q28475128-0B90A706-8638-4226-AE92-B65EB5C84F31Q28716029-D12CEDB7-EBFB-4F4A-8604-50C9925FD44AQ31144876-26E06FDE-3959-4AF8-8DE9-C009DC771BFAQ33362288-6EB9894B-7D69-42CE-ADFF-4E632074F967Q33494276-4BCA55D3-CBBD-44E7-B466-287585D60DE6Q33520512-8D98D7BB-8B53-4319-B8CE-66582C3FD866Q33532734-41C68CEC-7998-4382-82A8-2D8328C8A456Q33779928-0681D32C-D3A5-4487-A3F9-33AC57234090Q33849788-2BEFB194-26E3-43B6-9738-331975FD2387Q34058399-4B8F1219-F6E0-4CF5-9429-80B0833A07A3Q34459381-E84A886A-4BDA-4F58-8AD4-7878E374C05BQ34616650-FEB0FAA7-6312-4673-BBC9-87F4B71A65E0Q34712590-14BF316E-7219-4C10-8B1F-5FB29C02ACFDQ36403441-5DD40F0D-01B2-4DAB-9907-A1A823A647B1Q36558030-A29F6882-5A00-4BE3-B9F3-5FAEC21C113AQ36659064-A92B8F2A-6A48-4182-AA35-FE3D025C586DQ37346447-69F6C771-08D3-464D-B12B-0E7D5331BC34Q37417870-94F9DA1E-8474-4544-94C7-0199DBE15BB5Q37417906-F2D7C342-EF0E-4F25-84DB-2312503A244EQ37588421-4F231841-4C7C-423A-8518-AECE7C39DD3AQ37924161-CA8B3381-AFB8-4003-804A-127FD523D5CCQ38265614-B78652FF-233F-4A05-9514-58CDFF44C0EEQ38915649-7B2C5F70-D6FA-4E0D-9470-56622A85CFA2Q39072488-DDE2FC3F-82EC-486B-922F-E3DB7F0AD4EEQ40184254-713583F0-7A4A-44A9-9E86-F2AF8DC82C28Q42104288-839BE0C2-5F1F-4053-9AEC-1A8B3BBF69AAQ42409050-AA8F11B9-E0D9-43EF-A5D1-E4FC0AD4086FQ43122068-DBDCFD3B-319D-47BC-AC62-6CF1822EBD2BQ56893922-FCBCCE3E-3BA3-41EA-990F-BA65599F6E85
P2860
A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
A preclinical model for predic ...... rgeted AAVP molecular imaging.
@ast
A preclinical model for predic ...... rgeted AAVP molecular imaging.
@en
type
label
A preclinical model for predic ...... rgeted AAVP molecular imaging.
@ast
A preclinical model for predic ...... rgeted AAVP molecular imaging.
@en
prefLabel
A preclinical model for predic ...... rgeted AAVP molecular imaging.
@ast
A preclinical model for predic ...... rgeted AAVP molecular imaging.
@en
P2093
P2860
P356
P1476
A preclinical model for predic ...... rgeted AAVP molecular imaging.
@en
P2093
Amin Hajitou
Borys Korchin
Dina C Lev
Fernanda I Staquicini
Jonathan A F Hannay
Juri G Gelovani
Mian M Alauddin
Raphael E Pollock
Robert S Benjamin
Suren Soghomonyan
P2860
P304
P356
10.1073/PNAS.0712184105
P407
P577
2008-03-12T00:00:00Z